When it passed the Omnibus appropriations bill for the financial year 2018 at the end of last week, Congress increased funding for prostate cancer research from $80 to $100 million through the Department of Defense’s Congressionally Directed Medical Research Program (CDRMP). … READ MORE …
Filed under: Uncategorized | Tagged: CDMRP, DoD, funding, PCRP, research | 1 Comment »
The “New” Prostate Cancer InfoLink has heard that, as part of the final resolution of the US federal budget for fiscal year 2017 (which passed the Senate yesterday), there has been a $10 million increase in funding for the Prostate Cancer Research Program (PCRP) within the Department of Defense’s Congressionally Directed Medical Research Program (CDMRP). … READ MORE …
Filed under: Uncategorized | Tagged: 2017, budget, CDMRP, PCRP | 1 Comment »
According to the Report of the U.S. House of Representatives’ Committee on Appropriations (see p. 273) it is currently proposed that the Prostate Cancer Research Program of the Department of Defense’s Congressionally Directed Medical Research Program will again receive $80 million in funding for the financial year 2014. … READ MORE …
Filed under: Uncategorized | Tagged: CDMRP, DoD, funding, PCRP, research | 1 Comment »
As the annual Defense appropriations cycle starts once again, The “New” Prostate Cancer InfoLink encourages all you US-based prostate cancer patients and other US-based voters to e-mail your Congressman or Congresswoman and ask them to support prostate cancer research funding through the “Dear Colleague” letter being circulated by Representative Pete King in the House. … READ MORE …
Filed under: Diagnosis, Drugs in development, Living with Prostate Cancer, Management, Prevention, Risk, Treatment | Tagged: appropriations, CDMRP, DoD, funding, PCRP, research | 1 Comment »
It appears that research funding of $80 million will again be directed for use to study prostate cancer through the Department of Defense’s Congressionally Directed Medical Research Program (DoD CDMRP) for the financial year 2012. This is a big and important “win” for prostate cancer research during a time of fiscal constraint. … READ MORE …
Filed under: Uncategorized | Tagged: CDMRP, research | 3 Comments »
Many readers will already have seen the report we posted about Senator McCain’s desire to eliminate the Prostate Cancer Research Program within the Congressionally Directed Medical Research Program (CDMRP) — one of the most successful prostate cancer research initiatives. Now you can work with the rest of the advocacy community to counter this. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer | Tagged: advocacy, CDMRP, eliminate, McCain, Prostate Cancer Research Program | 3 Comments »
So the question any smart prostate cancer patient should ask himself — especially if he has any degree of good scientific education — is, “How do I get myself invited to the next IMPaCT meeting?” … READ MORE …
Filed under: Living with Prostate Cancer | Tagged: CDMRP, consumer reviewer, IMPACT, participate, Prostate Cancer Research Program | Leave a comment »
Most medical-scientific meetings that deal (at least in part) with prostate cancer are inhabited by academic scientists, clinicians, and various types of representative of commercial companies. … READ MORE …
Filed under: Living with Prostate Cancer, Management | Tagged: CDMRP, Department of Defense, IMPACT, Prostate Cancer Research Program | 2 Comments »
Senator John McCain is a man who has been treated successfully not once, not twice, but three times for malignant melanoma. … READ MORE …
Filed under: Uncategorized | Tagged: CDMRP, funding, McCain, PCRP, research | 7 Comments »
The Appropriations Defense subcommittee of the U.S. House of Representatives is to convene a hearing tomorrow (May 20, 2010), featuring public testimony regarding prostate cancer research within the Congressionally Directed Medical Research Program (CDMRP). … READ MORE …
Filed under: Uncategorized | Tagged: CDMRP, funding, hearing, Prostate Cancer Research Program | 1 Comment »
THE "NEW" PROSTATE CANCER INFOLINK 